Filing Flows

Filing Flows › Genesco (GCO) › Q3 FY26

Genesco (GCO) Q3 FY26 earnings results (third quarter fiscal 2026)

10-Q filed Dec 11, 2025

Genesco (GCO) reported revenue of $616M for the third quarter fiscal 2026 (Q3 FY26), +3% from a year earlier and +13% from the quarter before. Operating margin was 1.4%, net earnings $5.4M (0.9% of revenue).

Revenue$616M
Year over year+3%
Quarter over quarter+13%
Operating margin1.4%
Net earnings$5.4M

Genesco, Q3 FY26: revenue $616M (+3% year over year), operating margin 1.4%, net earnings $5.4M, operating cash flow −$12.9M. The chart follows the revenue to costs, profit and cash.

Q3 FY26AmountQ/QY/Y
Revenue$616M+13%+3%
Gross profit$289M+15%+1%
Operating profit$8.6M—-16%
Net earnings$5.4M——
Operating cash flow−$12.9M-115%—

What changed

Revenue was $616.2M in Q3 FY26, up 3% year over year and up 13% from the previous quarter. Journeys Group Segment was the largest line at 61% of revenue. Journeys Group Segment added $14.2M year over year (up 4%), 71% of the total change.

Gross margin was 46.8%, down 1.0 points from a year earlier. Operating profit was $8.6M, a 1.4% margin (down 0.3 points year over year). Operating profit fell $1.6M even though revenue rose $19.9M versus a year earlier, so costs grew faster than sales. Operating expenses grew 2% against revenue growth of 3%. Net earnings were $5.4M. The effective tax rate was 28.4%.

Operating cash flow was −$12.9M. Non-cash charges added back $13.4M of depreciation and amortization and $3.2M of share-based compensation. Working capital and other items used $34.8M. Capital expenditures of $18.6M exceeded it, leaving free cash flow of −$31.5M.

Questions

What was Genesco's revenue in the third quarter fiscal 2026?

Genesco (GCO) reported revenue of $616M for the third quarter fiscal 2026 (Q3 FY26), +3% from a year earlier and +13% from the quarter before.

Was Genesco profitable in the third quarter fiscal 2026?

Operating profit was $8.6M (1.4% of revenue) and net earnings $5.4M.

Open the interactive Sankey →

Source: Genesco 10-Q on SEC EDGAR.